Article
Treatment of Idiopathic Pulmonary Fibrosis.
Internal Medicine
Division
South Atlantic
Hospital
Grand Strand Medical Center
Document Type
Manuscript
Publication Date
5-1-2021
Keywords
- future management,
- ipf,
- literature review of disease,
- progressive interstitial lung disease,
- pulmonary disease
Disciplines
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown cause, occurring in adults and limited to the lungs. In the past, treatment was aimed at minimizing inflammation and slowing the progression of inflammation to fibrosis. However, the underlying lesion in IPF may be more fibrotic than inflammatory, explaining why few patients respond to anti-inflammatory therapies and the prognosis remains poor. In this review of literature, we will be focusing on main lines of treatment including current medications, supportive care, lung transplantation evaluation, and potential future strategies of treatment.
Publisher or Conference
Cureus
Citation Information
Abuserewa ST, Duff R, Becker G. Treatment of Idiopathic Pulmonary Fibrosis. Cureus. 2021;13(5):e15360. Published 2021 May 31. doi:10.7759/cureus.15360